US FDA globalisation bill awaits attention
This article was originally published in Clinica
Executive Summary
A bill that would create an inspectorate within the US FDA dedicated to inspecting foreign facilities is gathering co-sponsors but is still waiting for attention from the House energy and commerce committee.